Peter Anevski - 05 Oct 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Mark Livingston, Attorney-in-Fact
Issuer symbol: PGNY
Transactions as of: 05 Oct 2022
Net transactions value: -$975,209
Form type: 4
Filing time: 07 Oct 2022, 16:35:34 UTC
Previous filing: 12 Sep 2022
Next filing: 17 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGNY	Common Stock	Gift	$0	-74,471	-23%	$0.000000	250,445	05 Oct 2022	Direct
transaction	PGNY	Common Stock	Gift	$0	+74,471	+61%	$0.000000	196,598	05 Oct 2022	See footnote	F1
transaction	PGNY	Common Stock	Options Exercise	$5,688	+1,440	+0.57%	$3.95^*	251,885	05 Oct 2022	Direct
transaction	PGNY	Common Stock	Sale	$57,859	-1,440	-0.57%	$40.18	250,445	05 Oct 2022	Direct	F2
transaction	PGNY	Common Stock	Sale	$14,465	-360	-0.18%	$40.18	196,238	05 Oct 2022	See footnote	F1, F2
transaction	PGNY	Common Stock	Options Exercise	$77,428	+19,602	+7.8%	$3.95^*	270,047	06 Oct 2022	Direct
transaction	PGNY	Common Stock	Sale	$788,784	-19,602	-7.3%	$40.24	250,445	06 Oct 2022	Direct	F2, F3
transaction	PGNY	Common Stock	Sale	$197,216	-4,901	-2.5%	$40.24	191,337	06 Oct 2022	See footnote	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGNY	Option (Right to Buy)	Options Exercise	$0	-1,440	-0.1%	$0.000000	1,514,115	05 Oct 2022	Common Stock	1,440	$3.95	Direct	F4
transaction	PGNY	Option (Right to Buy)	Options Exercise	$0	-19,602	-1.3%	$0.000000	1,494,513	06 Oct 2022	Common Stock	19,602	$3.95	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
F2	Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.